Immunogenicity 10889
Sample ID
3678
Response
Negative
Tumor Type
Melanoma
Gene Symbol
IDH2
Transcript ID
None
HLA INFO
C*14:02
TCR INFO
No TCR info found!
Full length protein sequence (322 aa)
MWKSP
1
NGTIR
6
NILGG
11
TVFRE
16
PIICK
21
NIPRL
26
VPGWT
31
KPITI
36
GRHAH
41
GDQYK
46
ATDFV
51
ADRAG
56
TFKMV
61
FTPKD
66
GSGVK
71
EWEVY
76
NFPAG
81
GVGMG
86
MYNTD
91
ESISG
96
FAHSC
101
FQYAI
106
QKKWP
111
LYMST
116
KNTIL
121
KAYDG
126
RFKDI
131
FQEIF
136
DKHYK
141
TDFDK
146
NKIWY
151
EHRLI
156
DDMVA
161
QVLKS
166
SGGFV
171
WACKN
176
YDGDV
181
QSDIL
186
AQGFG
191
SLGLM
196
TSVLV
201
CPDGK
206
TIEAE
211
AAHGT
216
VTRHY
221
REHQK
226
GRPTS
231
TNPIA
236
SIFAW
241
TRGLE
246
HRGKL
251
DGNQD
256
LIRFA
261
QMLEK
266
VCVET
271
VESGA
276
MTKDL
281
AGCIH
286
GLSNV
291
KLNEH
296
FLNTT
301
DFLDT
306
IKSNL
311
DRALG
316
RQ
321
Mutation Information
DNA mutation:
None
Peptide Range:
203 ~ 227
Mut AA position:
215 (13 in Wild Type peptide)
Alignment
Wild Type:
"VLVCPDGKTIEAEAAHGTVTRHYRE
||||||||||||.||||||||||||
Mutant:
VLVCPDGKTIEADAAHGTVTRHYRE"
Clin Cancer Res, 2017
Isolation of T-Cell Receptors Specifically Reactive with Mutated Tumor-Associated Antigens from Tumor-Infiltrating Lymphocytes Based on CD137 ExpressionGene Name (from Reference) IDH2
Checkpoint
Blockade
None
ACT
None
Vaccination
None
Curative
Effect
None
minimal_peptide
None
Antigen
Type
TMG RNA
T-cell
Source
TILs
APC
Type
autologous DCs
Assay
ELISPOT assay